JD Health International revenue and financials
In the fiscal year ended December 2025, JD Health International reported revenue of ¥73.44B (+26.28% year over year). Net income was ¥5.38B, a net margin of 7.3%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +26.28%
- 2025 vs 2024
- Net income growth
- +29.16%
- 2025 vs 2024
- Net margin
- 7.3%
- 2024: 7.2%
How JD Health International is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 30.5% a year on average over the last 5 years
Compound annual growth rate: from ¥19.38B in 2020 to ¥73.44B in 2025.
Revenue has grown for 8 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −0.3% to 5.2%
Operating income over revenue, 2022 → 2025: 5.5 percentage points.
Profits turn into cash: free cash flow equal to 161% of net income
Totals for fiscal years 2023–2025: free cash flow ¥18.85B, net income ¥11.68B.
Shares outstanding up 44.7% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 4 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 73,441 | 58,160 | 53,530 | 46,736 | 30,682 | 19,383 | 10,842 | 8,169 | 5,553 |
| Cost of revenue | 55,242 | 44,851 | 41,665 | 36,845 | 23,485 | 14,465 | 8,030 | 6,190 | 4,173 |
| Gross profit | 18,199 | 13,309 | 11,865 | 9,892 | 7,197 | 4,917 | 2,812 | 1,979 | 1,380 |
| Selling, general and administrative | 12,767 | 10,815 | 10,008 | 8,969 | 7,708 | 3,957 | 2,042 | 1,458 | 1,002 |
| Research and development | 1,634 | 1,330 | 1,226 | 1,067 | 893 | 609 | 338 | 218 | 123 |
| Operating income | 3,798 | 1,163 | 631 | -145 | -1,404 | 352 | 432 | 303 | 256 |
| EBIT | 3,798 | 1,163 | 631 | -145 | -1,404 | 352 | 432 | 303 | 256 |
| EBITDA | 3,975 | 1,315 | 795 | -60.9 | -1,372 | 365 | 437 | 307 | 258 |
| Interest expense | 11.1 | 8.2 | 9.5 | 9.1 | 6.0 | 3.4 | 35.5 | 0.2 | 0.1 |
| Pre-tax income | 6,030 | 4,797 | 2,693 | 696 | -901 | -17,072 | -835 | 306 | 256 |
| Income tax | 663 | 640 | 550 | 313 | 171 | 163 | 137 | 91.3 | 77.4 |
| Net income | 5,375 | 4,162 | 2,142 | 380 | -1,074 | -17,234 | -972 | 215 | 179 |
| Net income to common shareholders | 5,375 | 4,162 | 2,142 | 380 | -1,074 | -17,234 | -972 | 215 | 179 |
| Basic EPS | 1.70 | 1.32 | 0.69 | 0.12 | -0.35 | -7.80 | -0.45 | — | — |
| Diluted EPS | 1.68 | 1.32 | 0.68 | 0.12 | -0.35 | -7.80 | -0.45 | — | — |
| Average shares (basic) | 3,163 | 3,143 | 3,124 | 3,107 | 3,095 | 2,209 | 2,149 | — | — |
| Average shares (diluted) | 3,196 | 3,160 | 3,164 | 3,144 | 3,095 | 2,209 | 2,149 | — | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 40,888 | 38,151 | 35,290 | 29,816 | 28,344 | 26,420 | 27,110 | 26,511 | 20,225 | 17,044 |
| Cost of revenue | 30,202 | 28,844 | 26,398 | 23,207 | 21,644 | 20,757 | 20,907 | 21,034 | 15,811 | 13,155 |
| Gross profit | 10,686 | 9,307 | 8,892 | 6,609 | 6,700 | 5,662 | 6,203 | 5,477 | 4,415 | 3,890 |
| Selling, general and administrative | 6,609 | 6,651 | 5,973 | 5,469 | 5,030 | 5,296 | 4,642 | 5,004 | 3,868 | 4,207 |
| Research and development | 909 | 898 | 736 | 685 | 645 | 610 | 617 | 580 | 487 | 491 |
| Operating income | 3,179 | 1,671 | 2,127 | 128 | 1,035 | -248 | 879 | -194 | 49.1 | -837 |
| EBIT | 3,179 | 1,671 | 2,127 | 128 | 1,035 | -248 | 879 | -194 | 49.1 | -837 |
| EBITDA | 3,363 | 1,728 | 2,247 | 177 | 1,138 | -192 | 987 | -161 | 100 | -830 |
| Interest expense | 8.7 | 6.9 | 4.2 | 4.2 | 4.0 | 5.1 | 4.4 | 4.2 | 4.9 | 3.6 |
| Pre-tax income | 4,251 | 3,166 | 2,864 | 2,357 | 2,439 | 862 | 1,831 | 318 | 377 | -556 |
| Income tax | 815 | 391 | 272 | 235 | 405 | 281 | 269 | 158 | 154 | 62.4 |
| Net income | 3,437 | 2,779 | 2,596 | 2,125 | 2,037 | 580 | 1,561 | 157 | 224 | -618 |
| Net income to common shareholders | 3,437 | 2,779 | 2,596 | 2,125 | 2,037 | 580 | 1,561 | 157 | 224 | -618 |
| Basic EPS | 1.08 | 0.88 | 0.82 | 0.68 | 0.65 | 0.19 | 0.50 | 0.05 | 0.07 | -0.20 |
| Diluted EPS | 1.07 | 0.87 | 0.81 | 0.67 | 0.65 | 0.19 | 0.49 | 0.05 | 0.07 | -0.20 |
| Average shares (basic) | 3,178 | 3,167 | 3,160 | 3,146 | 3,140 | 3,127 | 3,120 | 3,106 | 3,108 | 3,098 |
| Average shares (diluted) | 3,204 | 3,203 | 3,190 | 3,165 | 3,156 | 3,165 | 3,163 | 3,149 | 3,140 | 3,098 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 81,587 | 71,275 | 64,288 | 61,277 | 48,002 | 43,995 | 8,677 | 1,182 | 911 |
| Current assets | 56,349 | 58,460 | 47,850 | 56,447 | 45,705 | 42,705 | 8,624 | 1,166 | 901 |
| Cash and equivalents | 31,785 | 22,629 | 15,037 | 18,718 | 17,252 | 32,271 | 4,965 | 16.2 | 7.4 |
| Short-term investments | 15,864 | 18,169 | 16,799 | 27,951 | 23,637 | 6,525 | 1,395 | — | — |
| Receivables | 1,108 | 1,147 | 972 | 1,988 | 459 | 507 | 967 | 30.0 | 8.1 |
| Inventory | 6,858 | 5,843 | 5,085 | 5,996 | 3,041 | 1,732 | 1,278 | 1,115 | 884 |
| Net property, plant and equipment | 1,230 | 796 | 288 | 252 | 261 | 115 | 16.2 | 4.4 | 3.8 |
| Other intangible assets | 1,933 | 2,095 | 2,182 | 2,268 | 25.4 | 28.5 | 0.6 | 2.8 | 5.7 |
| Long-term investments | 21,644 | 9,584 | 13,197 | 1,523 | 1,031 | 714 | 7.5 | 7.4 | — |
| Current liabilities | 20,741 | 15,521 | 14,585 | 16,356 | 8,005 | 4,682 | 1,545 | 431 | 247 |
| Accounts payable | 16,587 | 12,484 | 11,340 | 11,143 | 5,710 | 2,900 | 445 | 340 | 173 |
| Long-term debt | — | — | — | — | — | — | 7,584 | — | — |
| Total debt | 636 | 258 | 215 | 199 | 201 | 90.0 | 7,596 | 3.1 | 3.3 |
| Total liabilities | 21,513 | 16,034 | 14,918 | 16,493 | 8,148 | 4,743 | 9,136 | 433 | 249 |
| Total equity (incl. minority) | 60,073 | 55,241 | 49,370 | 44,785 | 39,855 | 39,251 | -459 | 749 | 663 |
| Retained earnings | -7,971 | -13,224 | -17,336 | -19,382 | -19,715 | -18,603 | -1,369 | -94.8 | -54.0 |
| Minority interest | 1.4 | 9.7 | 14.5 | 4.3 | 1.2 | 0.5 | — | — | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 84,171 | 81,587 | 78,460 | 71,275 | 67,219 | 64,288 | 61,348 | 61,277 | 52,845 | 48,002 |
| Current assets | 58,107 | 56,349 | 58,228 | 58,460 | 54,968 | 47,850 | 56,456 | 56,447 | 50,611 | 45,705 |
| Cash and equivalents | 20,446 | 31,785 | 25,177 | 22,629 | 8,843 | 15,037 | 11,896 | 18,718 | 16,668 | 17,252 |
| Short-term investments | 15,584 | 15,864 | 19,757 | 18,169 | 26,741 | 16,799 | 34,029 | 27,951 | 25,003 | 23,637 |
| Receivables | 1,169 | 1,108 | 993 | 1,147 | 842 | 972 | 844 | 1,988 | 970 | 459 |
| Inventory | 7,384 | 6,858 | 7,455 | 5,843 | 5,681 | 5,085 | 5,136 | 5,996 | 3,627 | 3,041 |
| Net property, plant and equipment | 1,497 | 1,230 | 964 | 796 | 279 | 288 | 295 | 252 | 246 | 261 |
| Other intangible assets | 1,820 | 1,933 | 2,027 | 2,095 | 2,136 | 2,182 | 2,288 | 2,268 | 19.7 | 25.4 |
| Long-term investments | 22,477 | 21,644 | 16,869 | 9,584 | 9,161 | 13,197 | 1,579 | 1,523 | 982 | 1,031 |
| Current liabilities | 21,640 | 20,741 | 19,910 | 15,521 | 14,707 | 14,585 | 12,513 | 16,356 | 10,361 | 8,005 |
| Accounts payable | 17,609 | 16,587 | 16,603 | 12,484 | 11,624 | 11,340 | 9,320 | 11,143 | 7,564 | 5,710 |
| Total debt | 875 | 636 | 430 | 258 | 218 | 215 | 217 | 199 | 194 | 201 |
| Total liabilities | 22,715 | 21,513 | 20,483 | 16,034 | 15,079 | 14,918 | 12,653 | 16,493 | 10,491 | 8,148 |
| Total equity (incl. minority) | 61,456 | 60,073 | 57,977 | 55,241 | 52,140 | 49,370 | 48,694 | 44,785 | 42,355 | 39,855 |
| Retained earnings | -4,534 | -7,971 | -10,628 | -13,224 | -15,299 | -17,336 | -17,821 | -19,382 | -19,453 | -19,715 |
| Minority interest | 0.0 | 1.4 | 4.6 | 9.7 | 11.7 | 14.5 | 14.1 | 4.3 | 0.6 | 1.2 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10,174 | 4,332 | 4,605 | 5,905 | 3,431 | 3,699 | 409 | 187 | 36.1 |
| Depreciation and amortization | 280 | 215 | 227 | 141 | 63.2 | 27.2 | 7.4 | 6.3 | 3.1 |
| Capital expenditure | -151 | -46.4 | -61.2 | -40.2 | -502 | -15.7 | -5.2 | -2.0 | -0.8 |
| Investing cash flow | -591 | 3,146 | -8,023 | -4,236 | -17,752 | -7,843 | -1,449 | -13.7 | -8.6 |
| Financing cash flow | -79.2 | -45.6 | -117 | -925 | -164 | 32,029 | 6,509 | -2.9 | -33.3 |
| Share repurchases | — | 0.0 | -69.1 | -869 | -56.3 | — | — | — | — |
| Debt issued | — | — | — | — | — | — | 202 | — | — |
| Debt repaid | -68.1 | -37.4 | -33.8 | -47.6 | -32.3 | -243 | -1.5 | -2.8 | -33.2 |
| Effect of exchange rates | -348 | 159 | -145 | 721 | -533 | -580 | 41.0 | — | — |
| Net change in cash | 9,156 | 7,592 | -3,681 | 1,465 | -15,018 | 27,306 | 4,949 | 8.8 | 6.8 |
| Free cash flow | 10,023 | 4,286 | 4,544 | 5,865 | 2,929 | — | — | — | — |
| Levered free cash flow | 7,236 | 2,345 | 2,753 | 3,164 | 3,222 | 3,563 | 299 | 154 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4,461 | 3,929 | 6,245 | 2,102 | 2,230 | 4,237 | 368 | 3,649 | 2,256 | 1,497 |
| Depreciation and amortization | 184 | 160 | 120 | 111 | 103 | 120 | 108 | 89.7 | 51.0 | 37.4 |
| Capital expenditure | -90.5 | -115 | -36.1 | -33.2 | -13.2 | -21.7 | -39.5 | -18.8 | -21.4 | -480 |
| Investing cash flow | -14,352 | 2,966 | -3,556 | 11,519 | -8,373 | -783 | -7,240 | -1,425 | -2,811 | -2,725 |
| Financing cash flow | -911 | -48.9 | -30.3 | -23.8 | -21.8 | -98.7 | -18.5 | -294 | -632 | -137 |
| Share repurchases | -846 | — | — | — | — | -69.1 | — | -261 | -608 | -56.3 |
| Debt repaid | -56.2 | -41.9 | -26.1 | -19.6 | -17.8 | -24.5 | -9.4 | -28.5 | -19.1 | -8.4 |
| Effect of exchange rates | -538 | -239 | -110 | 188 | -29.5 | -214 | 68.7 | 120 | 602 | -363 |
| Net change in cash | -11,339 | 6,607 | 2,548 | 13,786 | -6,194 | 3,141 | -6,822 | 2,050 | -584 | -1,728 |
| Free cash flow | 4,371 | 3,814 | 6,209 | 2,069 | 2,217 | 4,215 | 329 | 3,630 | 2,235 | 1,017 |
| Levered free cash flow | 2,588 | 2,823 | 4,413 | 1,357 | 988 | 2,927 | -174 | 987 | 2,177 | 1,196 |
Financial statements of similar companies
Companies in the group: same and related industries, similar size
